Yoshihiro Ikehata

Juntendo University

Papers

1

Total Citations

1

H-Index

1

About

Yoshihiro Ikehata is a leading urological researcher whose work centers on improving outcomes for prostate cancer patients, particularly through the refinement of surgical and predictive techniques. His primary research areas include robotic-assisted surgery, biochemical recurrence (BCR) after radical prostatectomy, and the development of novel biomarkers for early cancer detection. Ikehata’s most significant contribution is his investigation into the prostate-specific antigen decline rate in the first month (PSADR1M) following robot-assisted radical prostatectomy. His 2025 study, which has already garnered attention, demonstrates that PSADR1M is a timely and powerful predictive factor for biochemical recurrence, offering clinicians a crucial early window to assess surgical success and tailor postoperative surveillance. This work enhances the precision of prognostic models, moving beyond traditional variables. By identifying a simple, early metric, Ikehata’s research empowers urologists to intervene sooner for high-risk patients, potentially improving long-term survival rates. His findings represent a practical step forward in personalized prostate cancer management, bridging the gap between surgical technique and patient outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Prostate-Specific Antigen Decline Rate in the First Month Is a Timely Predictive Factor for Biochemical Recurrence After Robot-Assisted Radical Prostatectomy
1 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Juntendo University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago